Sodium Nitroprusside for Advanced Low-Output Heart Failure
Wilfried Mullens, MD,
Zuheir Abrahams, MD, PhD,
Gary S. Francis, MD, FACC,
Hadi N. Skouri, MD,
Randall C. Starling, MD, MPH, FACC,
James B. Young, MD, FACC,
David O. Taylor, MD, FACC and
W.H. Wilson Tang, MD, FACC*
Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, Ohio.
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Clinical Outcomes According to Use of Sodium Nitroprusside
Kaplan-Meier curves of all cause mortality (A) and the combined end point of all-cause mortality and cardiac transplant (B) between patients who did and did not receive intravenous sodium nitroprusside during hospitalization.
|
|
|
